Skip to main content
Erschienen in: Infection 4/2012

01.08.2012 | Clinical and Epidemiological Study

Frequency of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India

verfasst von: S. Sankar, H. Narayanan, S. Kuppanan, B. Nandagopal

Erschienen in: Infection | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Extended-spectrum β-lactamase (ESBL) producers were reported only from hospital settings previously, but, nowadays, its common presence in community settings is evident from reports. Our primary aim was to assess the frequency of ESBL-producing Gram-negative bacteria (GNB) and their antibiogram pattern among the clinical isolates received during an 8-month time period.

Methods

The clinical isolates which belonged to the family Enterobacteriaceae from the clinical specimens were included in the study. These clinical isolates were tested for ESBL production using the double-disk synergy test.

Results

In total, 301 patients were included in this study, of which 146 (48.50 %) were found to harbor strains of ESBL producers. The acquisition of ESBL in relation to age, sex, inhabitancy, inpatients, and outpatients was also analyzed. In our study, 50.29 % of inpatients and 45.86 % of outpatients were found to harbor ESBL producers. The difference between the two groups was not statistically significant. We found five meropenem-resistant ESBL-producing strains among the 146 ESBL producers. Rural inhabitants were found to contain more ESBLs when compared to peri-urban inhabitants.

Conclusion

The study showed a high frequency of ESBLs in both community-acquired and hospital-acquired infections. The frequency of ESBLs was higher among isolates from patients who were from rural populations than those from peri-urban populations. The data on ESBL frequency suggests the need for a rational antibiotic use which would reduce the spread of ESBL-producing members of the family Enterobacteriaceae.
Literatur
1.
Zurück zum Zitat Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum β-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42:925–34.PubMedCrossRef Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum β-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42:925–34.PubMedCrossRef
2.
Zurück zum Zitat Jacobs RA, Chin-Hong PV. General problems in infectious diseases. In: McPhee SJ, Papadakis MA, Tierney LM, editors. Current medical diagnosis and treatment. 46th ed. New York: Lange; 2007. p. 1311–44. Jacobs RA, Chin-Hong PV. General problems in infectious diseases. In: McPhee SJ, Papadakis MA, Tierney LM, editors. Current medical diagnosis and treatment. 46th ed. New York: Lange; 2007. p. 1311–44.
3.
Zurück zum Zitat Myer RM, Koshi G. Manual of diagnostic procedures in medical microbiology and immunology/serology. Vellore: Christian Medical College and Hospital; 2000. p. 137–62. Myer RM, Koshi G. Manual of diagnostic procedures in medical microbiology and immunology/serology. Vellore: Christian Medical College and Hospital; 2000. p. 137–62.
4.
Zurück zum Zitat Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20. Wayne: CLSI; 2010. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20. Wayne: CLSI; 2010.
5.
Zurück zum Zitat Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997–2001). J Antimicrob Chemother. 2003;52:140–1.PubMedCrossRef Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997–2001). J Antimicrob Chemother. 2003;52:140–1.PubMedCrossRef
6.
Zurück zum Zitat Lalani T, Varkey JB, Drew R, et al. Analysis of two- and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms. Scand J Infect Dis. 2008;40:672–4.PubMedCrossRef Lalani T, Varkey JB, Drew R, et al. Analysis of two- and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms. Scand J Infect Dis. 2008;40:672–4.PubMedCrossRef
7.
Zurück zum Zitat Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:163–7.PubMedCrossRef Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:163–7.PubMedCrossRef
8.
Zurück zum Zitat Peña C, Gudiol C, Tubau F, et al. Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect. 2006;12:279–84.PubMedCrossRef Peña C, Gudiol C, Tubau F, et al. Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect. 2006;12:279–84.PubMedCrossRef
9.
Zurück zum Zitat Harris AD, McGregor JC, Johnson JA, et al. Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13:1144–9.PubMedCrossRef Harris AD, McGregor JC, Johnson JA, et al. Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13:1144–9.PubMedCrossRef
10.
Zurück zum Zitat Mumtaz S, Ahmad M, Aftab I, Akhtar N, ul Hassan M, Hamid A.. Extended spectrum beta-lactamases in enteric Gram-negative bacilli: related to age and gender. J Ayub Med Coll Abbottabad. 2007;19:107–11.PubMed Mumtaz S, Ahmad M, Aftab I, Akhtar N, ul Hassan M, Hamid A.. Extended spectrum beta-lactamases in enteric Gram-negative bacilli: related to age and gender. J Ayub Med Coll Abbottabad. 2007;19:107–11.PubMed
11.
Zurück zum Zitat Kumar MS, Lakshmi V, Rajagopalan R. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol. 2006;24:208–11.PubMed Kumar MS, Lakshmi V, Rajagopalan R. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol. 2006;24:208–11.PubMed
12.
Zurück zum Zitat Khan AU, Musharraf A. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Med Sci Monit. 2004;10:CR598–602.PubMed Khan AU, Musharraf A. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Med Sci Monit. 2004;10:CR598–602.PubMed
13.
Zurück zum Zitat Chatterjee B, Kulathinal S, Bhargava A, Jain Y, Kataria R. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in central India. Indian J Med Microbiol. 2009;27:329–34.PubMedCrossRef Chatterjee B, Kulathinal S, Bhargava A, Jain Y, Kataria R. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in central India. Indian J Med Microbiol. 2009;27:329–34.PubMedCrossRef
14.
Zurück zum Zitat Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011 May;11:355–62.PubMedCrossRef Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011 May;11:355–62.PubMedCrossRef
15.
Zurück zum Zitat Chaudhuri BN, Rodrigues C, Balaji V, et al. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India. 2011;59:287–92.PubMed Chaudhuri BN, Rodrigues C, Balaji V, et al. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India. 2011;59:287–92.PubMed
16.
Zurück zum Zitat Umadevi S, Kandhakumari G, Joseph NM, et al. Prevalence and antimicrobial susceptibility pattern of ESBL producing Gram negative bacilli. J Clin Diagn Res. 2011;5:236–9. Umadevi S, Kandhakumari G, Joseph NM, et al. Prevalence and antimicrobial susceptibility pattern of ESBL producing Gram negative bacilli. J Clin Diagn Res. 2011;5:236–9.
17.
Zurück zum Zitat Shriyan A, Sheetal R, Nayak N. Aerobic micro-organisms in post-operative wound infections and their antimicrobial susceptibility patterns. J Clin Diagn Res. 2010;4:3392–6. Shriyan A, Sheetal R, Nayak N. Aerobic micro-organisms in post-operative wound infections and their antimicrobial susceptibility patterns. J Clin Diagn Res. 2010;4:3392–6.
18.
Zurück zum Zitat Narayanaswamy A, Mallika M. Prevalence and susceptibility of extended spectrum beta-lactamases in urinary isolates of Escherichia coli in a tertiary care hospital Chennai—South India. Internet J Med Update. 2011;6:39–43. Narayanaswamy A, Mallika M. Prevalence and susceptibility of extended spectrum beta-lactamases in urinary isolates of Escherichia coli in a tertiary care hospital Chennai—South India. Internet J Med Update. 2011;6:39–43.
19.
Zurück zum Zitat Metri BC, Jyothi P, Peerapur BV. The prevalence of ESBL among Enterobacteriaceae in a tertiary care hospital of north Karnataka, India. J Clin Diagn Res. 2011;5:470–5. Metri BC, Jyothi P, Peerapur BV. The prevalence of ESBL among Enterobacteriaceae in a tertiary care hospital of north Karnataka, India. J Clin Diagn Res. 2011;5:470–5.
20.
Zurück zum Zitat Babypadmini S, Appalaraju B. Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae—prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004;22:172–4.PubMed Babypadmini S, Appalaraju B. Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae—prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004;22:172–4.PubMed
21.
Zurück zum Zitat Abhilash KPP, Veeraraghavan B, Abraham OC. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. J Assoc Physicians India. 2010;58:13–7.PubMed Abhilash KPP, Veeraraghavan B, Abraham OC. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. J Assoc Physicians India. 2010;58:13–7.PubMed
22.
Zurück zum Zitat Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8:557–84.PubMed Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8:557–84.PubMed
23.
Zurück zum Zitat Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54:969–76.PubMedCrossRef Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54:969–76.PubMedCrossRef
24.
Zurück zum Zitat Mathai E, Chandy S, Thomas K, et al. Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in southern India. Trop Med Int Health. 2008;13:41–5.PubMedCrossRef Mathai E, Chandy S, Thomas K, et al. Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in southern India. Trop Med Int Health. 2008;13:41–5.PubMedCrossRef
25.
Zurück zum Zitat Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect. 2008;14:159–65.PubMedCrossRef Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect. 2008;14:159–65.PubMedCrossRef
Metadaten
Titel
Frequency of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India
verfasst von
S. Sankar
H. Narayanan
S. Kuppanan
B. Nandagopal
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 4/2012
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0261-6

Weitere Artikel der Ausgabe 4/2012

Infection 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.